Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marwa O. El-Derany"'
Publikováno v:
Stem Cell Reviews and Reports. 17:1429-1445
Radiotherapy is an indispensable cancer treatment approach. However, it is associated with hazardous consequences on multiple organs characterized by insidious worsening severity over time. This study aimed to examine the potential therapeutic effect
Autor:
Marwa O. El-Derany
Publikováno v:
Al-Azhar Journal of Pharmaceutical Sciences. 60:111-121
Chronic hepatitis C (CHC) treatment modalities dramatically evolve, however some patients still suffer treatment failure with sever aggressive side effects. Accordingly personalizing antiviral treatment becomes an urgent cornerstone in treatment path
Autor:
Sayed A. Sayed, Hala O. El-Mesallamy, Marwa O. El-Derany, Sara A. Wahdan, Al-Aliaa M. Sallam, Rana K. El-Asfar, Ebtehal El-Demerdash
Publikováno v:
European journal of pharmacology. 908
Background and aim Tamoxifen (TAM) therapy has been associated with fatty liver diseases. Recently, multiple reports have also shown that TAM is related to cognitive impairment in patients with breast cancer. Luteolin, a natural flavonoid, has been t
Autor:
Marwa O. El-Derany
Publikováno v:
Biology
Biology, Vol 9, Iss 75, p 75 (2020)
Volume 9
Issue 4
Biology, Vol 9, Iss 75, p 75 (2020)
Volume 9
Issue 4
Background: non-alcoholic steatohepatitis (NASH) recently headlined hepatocellular carcinoma (HCC) worldwide. This study aims to unveil the role of some unaddressed critical players that might aid in understanding, predicting, and targeting NASH and
Publikováno v:
Biochemical Pharmacology. 190:114624
Non-alcoholic steatohepatitis (NASH) has evolved as the most common and devastating chronic liver disease. This study aimed to explore the underlined mechanism for the therapeutic potentials of bone marrow mesenchymal stem cells (BM-MSCs) and their d
Publikováno v:
Cancer Research. 81:2344-2344
Purpose: The future prevalence of hepatocellular carcinoma (HCC) is expected to become further divergent with the emergence of non-alcoholic steatohepatitis (NASH) as a major contributor. Multiple etiologies are associated with the development of HCC
Autor:
Mohamed A. Awwad, Manar M. Gharib, Muhannad H. Kasem, Mahmoud M. Eltobgy, Ahmed S. Moubarak, Ahmed S. Al-Tawashi, Ahmed Mostafa, Hazem Omar, Marwa O. El-Derany, Ahmed Alaa, Hesham A. Saafan
Publikováno v:
Virus Research. 292:198226
Suspect has been directed towards some direct acting antivirals (DAAs) due to their reported association with hepatocellular carcinoma (HCC) development in chronic hepatitis C (CHC) patients. The mechanisms behind HCC development, following CHC treat
Publikováno v:
Biochemical Pharmacology. 177:113942
Non‐alcoholic steatohepatitis (NASH) is a devastating form of non‐alcoholic fatty liver disease (NAFLD). Pyrvinium pamoate (PP) has been recently introduced as anti-adipogenic compound. We aimed to investigate the effects of PP on high fat diet (